Bleeding risk factors associated with argatroban therapy in the critically ill.
about
The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution.Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trialSafety and economic considerations of argatroban use in critically ill patients: a retrospective analysisMonitoring of Argatroban and Lepirudin.Pathophysiology of Cardiopulmonary Bypass: Current Strategies for the Prevention and Treatment of Anemia, Coagulopathy, and Organ Dysfunction.Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support.Early initiation of argatroban therapy in the management of acute superior mesenteric venous thrombosis.Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.
P2860
Q33412990-22349645-3CEF-479D-8E48-0558D4A68010Q33418376-D324711B-15D4-42FA-85A4-DF4E2ADD676BQ33422064-796E4252-A3FB-4270-AB9D-62E919CB1250Q33440268-0A04A822-F182-48CA-813D-41F8D72E7E86Q38215982-B9D3771A-3967-48F1-B8D0-4434E88319C1Q38641761-8D4A8113-856E-4C2B-8185-054A48673B65Q42293011-69790270-0F86-4531-9BB8-748945E545B0Q50050785-F17799F0-8977-4ADD-B02E-E5581F2479E6
P2860
Bleeding risk factors associated with argatroban therapy in the critically ill.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Bleeding risk factors associated with argatroban therapy in the critically ill.
@ast
Bleeding risk factors associated with argatroban therapy in the critically ill.
@en
type
label
Bleeding risk factors associated with argatroban therapy in the critically ill.
@ast
Bleeding risk factors associated with argatroban therapy in the critically ill.
@en
prefLabel
Bleeding risk factors associated with argatroban therapy in the critically ill.
@ast
Bleeding risk factors associated with argatroban therapy in the critically ill.
@en
P2093
P2860
P1476
Bleeding risk factors associated with argatroban therapy in the critically ill.
@en
P2093
Anthony T Gerlach
Bruce Doepker
Claire V Murphy
Gary S Philips
Kari L Mount
Lindsay J Ryder
P2860
P2888
P304
P356
10.1007/S11239-012-0758-Y
P577
2012-11-01T00:00:00Z